ReGENE LLC Profile last edited on: 3/11/2025
CAGE: -----
UEI: U1CES2AME9A8
Business Identifier: Biotechnology Research 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 01
County: Hampshire
Congr. District: 01
County: Hampshire
Public Profile
ReGENE LLC is a biotechnology startup with a mission to develop anti-aging therapy based on the synthesis of the evolutionary and molecular understanding of aging mechanisms. ReGENE operates at the Baystate Research Facility (Springfield, MA) and capitalizes on the strong research environment of the state of Massachusetts.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 1739895298 | 2 | NIH | $499,990 | |
| Project Title: Targeting Type 3 Diabetes (T3D) Mechanism of Alzheimer's Disease (AD) and AD-Related Dementias | ||||
Key People / Management
Alexander Suvorov -- CEO
Mila Getmansky -- Founder & Board of Directors Member
Charles Joseph -- Senior Director Computational Design
Karl Ruping -- Board of Directors Member
Gregory S. -- Consultant Drug Discovery Medicinal Chemistry Dmpk
Woody Sherman -- Adviser
Mila Getmansky -- Founder & Board of Directors Member
Charles Joseph -- Senior Director Computational Design
Karl Ruping -- Board of Directors Member
Gregory S. -- Consultant Drug Discovery Medicinal Chemistry Dmpk
Woody Sherman -- Adviser
Company News
There are no news available.
